Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kaveh Nezafati

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Drugs in Dermatology : JDD|March 4, 2026
Topical Ruxolitinib Therapy Decreases Rates of Depression and Anxiety: A Retrospective Analysis in Vitiligo PatientsRacha Cherradi, Rohan Ahuja, Kaveh Nezafati
JAAD Case Reports|October 14, 2024
Novel association of eosinophilic pustular folliculitis with systemic lupus erythematosus: A case reportTyler B Cepica, Rohit Gupta, Kaveh Nezafati
JAAD Case Reports|October 3, 2022
Linear lichenoid pigmented purpura: An unusual histopathologic patternZoha K Momin, Travis W Vandergriff, Kaveh Nezafati
JAAD Case Reports|October 29, 2024
Hyper-dilute botulinum toxin as an effective treatment for refractory erythromelalgiaAriel Brown, Duaa AbdelHameid, Kaveh Nezafati, et al.
JAAD Case Reports|November 3, 2023
Diffuse purpuric eruption in a patient with acute myeloid leukemiaZoha K Momin, Aya Alame, Travis Vandergriff, et al.
JAAD International|July 3, 2025
Association between lichen planus, psychiatric comorbidities, and psychiatric medication useAlexander Wu, Angela Rosenberg, Lauren DeBusk, et al.
Journal of the American Academy of Dermatology|June 19, 2012
How residency programs can foster practice for the underservedGabriela Blanco, Rebecca Vasquez, Kaveh Nezafati, et al.
Dermatology Online Journal|June 5, 2026
Lichen planus autoimmune comorbidities: A retrospective case control studyAngela L Rosenberg, Alexander Wu, Lauren DeBusk, et al.
The Journal of Investigative Dermatology|June 17, 2014
DC-HIL+ CD14+ HLA-DR no/low cells are a potential blood marker and therapeutic target for melanomaJake Turrentine, Jin-Sung Chung, Kaveh Nezafati, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Drugs in Dermatology : JDD|March 4, 2026
Topical Ruxolitinib Therapy Decreases Rates of Depression and Anxiety: A Retrospective Analysis in Vitiligo PatientsRacha Cherradi, Rohan Ahuja, Kaveh Nezafati
JAAD Case Reports|October 14, 2024
Novel association of eosinophilic pustular folliculitis with systemic lupus erythematosus: A case reportTyler B Cepica, Rohit Gupta, Kaveh Nezafati
JAAD Case Reports|October 3, 2022
Linear lichenoid pigmented purpura: An unusual histopathologic patternZoha K Momin, Travis W Vandergriff, Kaveh Nezafati
JAAD Case Reports|October 29, 2024
Hyper-dilute botulinum toxin as an effective treatment for refractory erythromelalgiaAriel Brown, Duaa AbdelHameid, Kaveh Nezafati, et al.
JAAD Case Reports|November 3, 2023
Diffuse purpuric eruption in a patient with acute myeloid leukemiaZoha K Momin, Aya Alame, Travis Vandergriff, et al.
JAAD International|July 3, 2025
Association between lichen planus, psychiatric comorbidities, and psychiatric medication useAlexander Wu, Angela Rosenberg, Lauren DeBusk, et al.
Journal of the American Academy of Dermatology|June 19, 2012
How residency programs can foster practice for the underservedGabriela Blanco, Rebecca Vasquez, Kaveh Nezafati, et al.
Dermatology Online Journal|June 5, 2026
Lichen planus autoimmune comorbidities: A retrospective case control studyAngela L Rosenberg, Alexander Wu, Lauren DeBusk, et al.
The Journal of Investigative Dermatology|June 17, 2014
DC-HIL+ CD14+ HLA-DR no/low cells are a potential blood marker and therapeutic target for melanomaJake Turrentine, Jin-Sung Chung, Kaveh Nezafati, et al.
Pageof 1